Gastroenterology and Hepatology

Track23:Genetic Markers for Predicting Inflammatory Responses in Liver Disease

Liver diseases such as Non-Alcoholic Fatty Liver Disease (NAFLD), hepatitis, and cirrhosis are often driven by complex inflammatory processes that are influenced by both genetic and environmental factors. Identifying genetic markers that predict inflammatory responses is crucial for early diagnosis, prognosis, and personalized treatment strategies. This track will explore the latest research on genetic biomarkers that can help predict and monitor inflammatory responses in liver diseases.

Specific genes involved in immune regulation, inflammation, and liver cell apoptosis are being studied to understand their role in disease progression. Markers such as IL-6, TNF-alpha, and NLRP3 inflammasome have been implicated in chronic liver inflammation, leading to fibrosis and cirrhosis. Additionally, recent advancements in genomic technologies are enabling researchers to identify single nucleotide polymorphisms (SNPs) and gene expression profiles that are linked to variations in inflammatory responses among individuals.

This session will delve into the latest advancements in genetic markers for liver disease, highlighting their potential for improving clinical outcomes and informing future therapeutic strategies.